title: Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
abstract: Epidermodysplasia verruciformis (EV) is a rare disorder characterized by disseminated cutaneous warts in predisposed patients who are highly susceptible to genus ß-papillomavirus infections. We present the case of a 40-year-old lymphocytopenic woman with a balanced chromosomal translocation and a 25-year history of refractory EV that was successfully treated with squaric acid dibutylester (SADBE) contact immunotherapy.
authors.forename: Jessica
authors.initials: J
authors.lastname: Kehdy
authors.forename: Corrine
authors.initials: C
authors.lastname: Erickson
authors.forename: Peter
authors.initials: P
authors.lastname: Rady
authors.forename: Stephen
authors.initials: S
authors.lastname: Tyring
authors.affiliation: 419 W Redwood St, Ste 240, Baltimore, MD 21201, USA. agasp001@umaryland.edu.
authors.forename: Anthony A
authors.initials: AA
authors.lastname: Gaspari
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000328:Adult; D003503:Cyclobutanes / Q000008:administration & dosage* / Q000627:therapeutic use; D004819:Epidermodysplasia Verruciformis / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; C020637:squaric acid dibutyl ester